As villous adenomas are more likely to be dysplastic than tubular adenomas and closer in progression to CRC, it is possible that changes in cellular immunity such as altered levels of immune markers, IL-12 and IFN-γ, could contribute to cancer development. The gene discussed is IFNG; the disease is tubular adenoma.